HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target
BioCardia Analyst Ratings
BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure
BioCardia Inc (BCDA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
12 Health Care Stocks Moving In Friday's Pre-Market Session
BioCardia Regains Full Compliance With Nasdaq Listing Requirements
Catalyst Watch: FOMC, FedEx Earnings, Electronic Arts Event, and Triple Witching Day
Peering Into BioCardia's Recent Short Interest
Why BioCardia (BCDA) Stock Is Falling Today
BioCardia Shares Resume Trade Following Circuit Breaker Halt
BioCardia Shares Drop 10% After Public Offering Prices
Top Premarket Decliners
Press Release: BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Crude Oil Moves Higher; Dollar General Earnings Miss Estimates
XORTX Therapeutics XRTX Research; BioCardia BCDA Device Clearance
Dow Jumps Over 100 Points; Nvidia Earnings Top Views
Why BioCardia (BCDA) Stock Is Up 95% Today
Sector Update: Health Care Stocks Advance Premarket Thursday
Traders Digest Nvidia Earnings, Upward Revision in Q2 Growth Data as US Equity Futures Rise Pre-Bell